Leading global law firm Herbert Smith Freehills has advised Goldman Sachs, as placing agent, on the Hong Kong and US aspects of the US$700 million private placement and issuance of shares of China Jinmao Holdings Group Limited (Jinmao).
Jinmao is a subsidiary of state-owned Sinochem Group, engaging in city operations, property development, commercial leasing, retail operations, hotel operations, finance and services.
The placement comprises approximately 602,340,000 new shares at a price of HK$5.70 per share. These shares account for approximately 5.11% of the existing issued capital of Jinmao and approximately 4.86% of the issued share capital as enlarged by the placing. In addition, Sinochem Hong Kong (Group) Company Limited, Jinmao’s controlling shareholder, subscribed for 349,450,000 new shares at the price of HK$5.70 per share. Proceeds from the placement and subscription will be used for land bidding, debt repayment and the company’s general working capital.
“We are delighted to have worked with Goldman Sachs, with which we have maintained a robust and long-standing partnership,” said Hong Kong partner Matt Emsley. “Once again, we have received extremely positive client feedback on our advice which helped them navigate through complex regulatory and legal issues.”
Matt Emsley led the team advising Goldman Sachs on the placement, assisted by senior consultant Jeremy Shen and associate Stephanie Chan. Singapore partner Siddhartha Sivaramakrishnan, and senior associates George Wu and Jin Kong in Hong Kong advised on US securities aspect of this transaction.
国际知名的律师事务所史密夫斐尔为高盛在中国房地产开发商中国金茂控股集团有限公司 (以下简称“中国金茂”) 的新股配售及认购中作为配售代理就香港和美国法律提供咨询。
中国金茂以每股5.70港元配售6.0234亿股新股份，约占现有已发行股本约5.11%，以及经配售事项扩大的公司已发行股本约4.86%，配售所得款项净额预计约34.16亿港元。此外，中国金茂的直接控股股东中化香港 (集团) 有限公司以每股5.70港元认购3.4945亿股新股，持股比例由原来的35.03%增至35.15%。认购所得款项净额预计约19.92亿港元。配售事项及认购事项的所得款项将用作竞投土地、偿还债款及集团的一般运营资金。
史密夫斐尔香港办公室合伙人艾迈修 (Matt Emsley) 表示：“我们很高兴与高盛合作，双方保持了牢固而长久的合作伙伴关系。在该项目中，我们解决了复杂的监管和法律问题，并再一次收到了来自客户方面非常积极的反馈。”
合伙人艾迈修领导团队为高盛在此次配售中提供法律服务，沈志良 (Senior Consultant)、陈颖瑜 (Associate) 提供支持。新加坡合伙人Siddhartha Sivaramakrishnan以及香港办公室吴卓人 (Senior Associate) 和孔瑾 (Senior Associate) 就该笔交易的美国证券方面事宜提供咨询。